French fluorescence technology firm Cisbio is hoping to benefit from an exclusive agreement with nascent lanthanide tech shop Lumiphore that will enable it to upgrade its HTRF line of time-resolved fluorescence resonance energy transfer assays with Lumiphore’s proprietary Lumi4 technology.
Cisbio will incorporate Lumi4 into its entire product catalog by replacing its currently used fluorophore with Lumi4 to “the greatest extent possible,” according to Lumiphore’s chief operating officer, Willem Spiegel.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

National Geographic reports that marine mammals have lost a gene that could make them more susceptible to organophosphate damage.

NPR reports on Human Cell Atlas Consortium's effort to catalog all the different cell types within the human body.

The Union of Concerned Scientists surveyed US government scientists about Trump Administration policies and more, Science reports.

In PNAS this week: history and genetic diversity of the scarlet macaw, approach for predicting human flu virus evolution, and more.